We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Updated advice for healthcare professionals is available, after conclusion of a review of the safety of idelalisib, including the risk of infection.
There are new interim treatment recommendations for idelalisib for chronic lymphocytic leukaemia and follicular lymphoma in light of new findings from clinical trials outside its currently authorised drug combinations or indicated populations.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Advice and guidance on the health needs of migrant patients from El Salvador for healthcare practitioners.
Product Safety Report for Esapharma Movate Steroid Cream presenting a serious chemical risk.
Check the tariff classification for impregnated glass fibre weave articles.
Urgent safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Product Recall for Vincenza Jewellery Pave Zircon Initial Cord Bracelet presenting a serious chemical risk.
Guidance and resources to resolve common fingermark visualisation queries and help forensic laboratories achieve and maintain ISO 17025.
Product Safety Report for Skin Gard Lightening Lotion presenting a serious chemical risk.
Product Safety Report for SIVOP Parfums & Cosmétiques Clair-Liss Lightening Body Cream presenting a serious chemical risk.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
How to apply for marketing authorisation via this new procedure.
Information on variants of the SARS-CoV-2 virus.
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
Cais am daliad niwed personol yn dilyn digwyddiad unigol
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.